Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

This publication has 43 references indexed in Scilit:

• Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
• HIV/AIDS preventive vaccine ‘prime-boost’ phase III trial: foundations and initial lessons learned from Thailand
  AIDS, 2006
• The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia
  Sexually Transmitted Infections, 2004
• Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
  AIDS, 1998
• HIV/AIDS Prevention in Thailand: Success and Challenges
  Science, 1998
• Changes in Sexual Behavior and a Decline in HIV Infection among Young Men in Thailand
  New England Journal of Medicine, 1996
• Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network
  JAMA, 1994
• Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases
  The Lancet, 1994
• Risk factors for HIV infection among young adult men in northern Thailand
  1993
• The epidemiology of HIV infection and AIDS in Thailand
  AIDS, 1991